Breast cancer nanophotodynamic therapy: curcumin nanohybrid as potential drug delivery system
Publish place: 11th International Breast Cancer Congress
Publish Year: 1394
نوع سند: مقاله کنفرانسی
زبان: English
View: 423
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ICBCMED11_149
تاریخ نمایه سازی: 21 اردیبهشت 1397
Abstract:
Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)- 1,6-heptadiene-3,5- dione), an active compound of Curcuma longa, have been found to be very potent anticancer agent against many different types of cancer cells. Recent studies show that curcumin can be used as a photosensitizer in photodynamic therapy for cancer treatment. However, the major disadvantage of curcumin is its poor aqueous solubility. To improve its applicability in cancer therapy, we intercalated curcumin into layered double hydroxide (LDH) and used as a nanohybrid photosensitizer in photodynamic therapy of human breast cancer cells. Powder X-ray diffraction (XRD), TEM and SEM microscopy analyses indicate that curcumin is stabilized in the host interlayer. According to the spectroscopy results, the water solubility and dispersity of intercalated curcumin increased and loading amount of curcumin in LDH is about 50%. The photodynamic effect of curcumin and the curcumin– LDH nanohybrid was studied on the MDA-MB-123 human breast cancer cell line. The Cell viability studies revealed that the curcumin–LDH nanohybrid were able to show more effective photodynamic effects on the cancer cells as compared to free curcumin. These results suggest that the biocompatible layered double hydroxide can be used as the basis of a tunable curcumin delivery carrier for photodynamic therapy in breast cancer treatment.
Keywords:
Authors
Khatereh Khorsandi
Medical Laser Research Center, ACECR, Tehran, Iran
Reza Hosseinzadeh
Medical Laser Research Center, ACECR, Tehran, Iran
Maryam jahanshiri-moghadam
Medical Laser Research Center, ACECR, Tehran, Iran